Clinical Report: Mechanisms and Therapeutic Promise of Electroacupuncture for NAFLD
Overview
Electroacupuncture (EA) shows promise as an adjunctive treatment for non-alcoholic fatty liver disease (NAFLD), improving hepatic steatosis and metabolic parameters. This review highlights the mechanisms through which EA influences lipid metabolism, inflammation, and insulin signaling.
Background
NAFLD is the most prevalent chronic liver disorder globally, affecting approximately one-third of adults. The disease is closely linked to obesity and metabolic dysfunction, often progressing silently to severe complications like cirrhosis. With no approved pharmacological therapies available, exploring adjunctive treatments like electroacupuncture is critical for managing this growing public health issue.
Data Highlights
Electroacupuncture has been shown to improve hepatic steatosis and metabolic parameters with minimal side effects, as indicated by preclinical studies and emerging clinical trials.
Key Findings
EA modulates hepatic lipid metabolism through pathways such as AMPK and SIRT1.
It influences insulin signaling and reduces inflammation via the NF-κB pathway.
Preclinical studies indicate EA effectively improves liver function and metabolic parameters.
EA has minimal side effects compared to conventional pharmacological therapies.
The need for further translational research on EA's efficacy in clinical settings is emphasized.
Clinical Implications
Electroacupuncture may serve as a beneficial adjunctive therapy for patients with NAFLD, particularly in those who struggle with lifestyle modifications. Clinicians should consider integrating EA into comprehensive treatment plans while awaiting further clinical validation.
Conclusion
Electroacupuncture presents a promising therapeutic strategy for NAFLD, warranting further investigation to establish its role in clinical practice.
